Christophe Blanquart

This study develops a vascularized mesothelioma-on-chip model to evaluate oncolytic measles virus effects on the tumor microenvironment.

This study investigates how NSCLC cells reprogram endothelial cells into tumor endothelial cells, altering immune cell behavior in vitro.

This study shows that blocking IL-27 reduces CD39 expression in tumor cells and enhances anti-PD-L1 therapy effectiveness.